Literature DB >> 27414760

A real-time fluorometric method for the simultaneous detection of cell death type and rate.

Sasker Grootjans1,2, Behrouz Hassannia1,2, Iris Delrue1,2, Vera Goossens1,2, Bartosz Wiernicki1,2, Yves Dondelinger1,2, Mathieu J M Bertrand1,2, Dmitri V Krysko1,2, Marnik Vuylsteke3, Peter Vandenabeele1,2,4, Tom Vanden Berghe1,2.   

Abstract

Several cell death assays have been developed based on a single biochemical parameter such as caspase activation or plasma membrane permeabilization. Our fluorescent apoptosis/necrosis (FAN) assay directly measures cell death and distinguishes between caspase-dependent apoptosis and caspase-independent necrosis of cells grown in any multiwell plate. Cell death is monitored in standard growth medium as an increase in fluorescence intensity of a cell-impermeable dye (SYTOX Green) after plasma membrane disintegration, whereas apoptosis is detected through caspase-mediated release of a fluorophore from its quencher (DEVD-amc). The assay determines the normalized percentage of dead cells and caspase activation per condition as an end-point measurement or in real time (automated). The protocol can be applied to screen drugs, proteins or siRNAs for interference with cell death while simultaneously detecting cell death modality switching between apoptosis and necrosis. Initial preparation may take up to 5 d, but the typical hands-on time is ∼2 h.

Entities:  

Mesh:

Year:  2016        PMID: 27414760     DOI: 10.1038/nprot.2016.085

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  39 in total

Review 1.  Necroptosis and its role in inflammation.

Authors:  Manolis Pasparakis; Peter Vandenabeele
Journal:  Nature       Date:  2015-01-15       Impact factor: 49.962

2.  MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates.

Authors:  Yves Dondelinger; Wim Declercq; Sylvie Montessuit; Ria Roelandt; Amanda Goncalves; Inge Bruggeman; Paco Hulpiau; Kathrin Weber; Clark A Sehon; Robert W Marquis; John Bertin; Peter J Gough; Savvas Savvides; Jean-Claude Martinou; Mathieu J M Bertrand; Peter Vandenabeele
Journal:  Cell Rep       Date:  2014-05-09       Impact factor: 9.423

3.  Identifying druglike inhibitors of myelin-reactive T cells by phenotypic high-throughput screening of a small-molecule library.

Authors:  Christina Rossi; Deepa Padmanaban; Jake Ni; Li-An Yeh; Marcie A Glicksman; Hanspeter Waldner
Journal:  J Biomol Screen       Date:  2007-05-03

4.  Differential signaling to apoptotic and necrotic cell death by Fas-associated death domain protein FADD.

Authors:  Tom Vanden Berghe; Geert van Loo; Xavier Saelens; Maria Van Gurp; Greet Brouckaert; Michael Kalai; Wim Declercq; Peter Vandenabeele
Journal:  J Biol Chem       Date:  2003-12-10       Impact factor: 5.157

5.  Tumour necrosis factor-induced necrosis versus anti-Fas-induced apoptosis in L929 cells.

Authors:  D Vercammen; P Vandenabeele; R Beyaert; W Declercq; W Fiers
Journal:  Cytokine       Date:  1997-11       Impact factor: 3.861

6.  Structure-function characterization of phenanthridinium compounds as mutagens in Salmonella.

Authors:  M Fukunaga; L W Yielding
Journal:  Mutat Res       Date:  1983-08       Impact factor: 2.433

7.  Tipping the balance between necrosis and apoptosis in human and murine cells treated with interferon and dsRNA.

Authors:  M Kalai; G Van Loo; T Vanden Berghe; A Meeus; W Burm; X Saelens; P Vandenabeele
Journal:  Cell Death Differ       Date:  2002-09       Impact factor: 15.828

8.  Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation.

Authors:  Young Sik Cho; Sreerupa Challa; David Moquin; Ryan Genga; Tathagat Dutta Ray; Melissa Guildford; Francis Ka-Ming Chan
Journal:  Cell       Date:  2009-06-12       Impact factor: 41.582

9.  EndoG links Bnip3-induced mitochondrial damage and caspase-independent DNA fragmentation in ischemic cardiomyocytes.

Authors:  Jisheng Zhang; Junmei Ye; Albert Altafaj; Maria Cardona; Núria Bahi; Marta Llovera; Xavier Cañas; Stuart A Cook; Joan X Comella; Daniel Sanchis
Journal:  PLoS One       Date:  2011-03-17       Impact factor: 3.240

10.  RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL.

Authors:  Kate E Lawlor; Nufail Khan; Alison Mildenhall; Motti Gerlic; Ben A Croker; Akshay A D'Cruz; Cathrine Hall; Sukhdeep Kaur Spall; Holly Anderton; Seth L Masters; Maryam Rashidi; Ian P Wicks; Warren S Alexander; Yasuhiro Mitsuuchi; Christopher A Benetatos; Stephen M Condon; W Wei-Lynn Wong; John Silke; David L Vaux; James E Vince
Journal:  Nat Commun       Date:  2015-02-18       Impact factor: 14.919

View more
  21 in total

1.  When PERK inhibitors turn out to be new potent RIPK1 inhibitors: critical issues on the specificity and use of GSK2606414 and GSK2656157.

Authors:  Diego Rojas-Rivera; Tinneke Delvaeye; Ria Roelandt; Wim Nerinckx; Koen Augustyns; Peter Vandenabeele; Mathieu J M Bertrand
Journal:  Cell Death Differ       Date:  2017-04-28       Impact factor: 15.828

Review 2.  The impact of non-genetic heterogeneity on cancer cell death.

Authors:  Zintis Inde; Scott J Dixon
Journal:  Crit Rev Biochem Mol Biol       Date:  2017-12-18       Impact factor: 8.250

3.  Synthesis of a HyCoSuL peptide substrate library to dissect protease substrate specificity.

Authors:  Marcin Poreba; Guy S Salvesen; Marcin Drag
Journal:  Nat Protoc       Date:  2017-09-21       Impact factor: 13.491

4.  Systematic Quantification of Population Cell Death Kinetics in Mammalian Cells.

Authors:  Giovanni C Forcina; Megan Conlon; Alex Wells; Jennifer Yinuo Cao; Scott J Dixon
Journal:  Cell Syst       Date:  2017-06-07       Impact factor: 10.304

5.  Yersinia remodels epigenetic histone modifications in human macrophages.

Authors:  Indra Bekere; Jiabin Huang; Marie Schnapp; Maren Rudolph; Laura Berneking; Klaus Ruckdeschel; Adam Grundhoff; Thomas Günther; Nicole Fischer; Martin Aepfelbacher
Journal:  PLoS Pathog       Date:  2021-11-18       Impact factor: 6.823

6.  Novel Iron Oxide Nanoparticles Induce Ferroptosis in a Panel of Cancer Cell Lines.

Authors:  Roberto Fernández-Acosta; Claudia Iriarte-Mesa; Daniel Alvarez-Alminaque; Behrouz Hassannia; Bartosz Wiernicki; Alicia M Díaz-García; Peter Vandenabeele; Tom Vanden Berghe; Gilberto L Pardo Andreu
Journal:  Molecules       Date:  2022-06-21       Impact factor: 4.927

7.  Cancer cells dying from ferroptosis impede dendritic cell-mediated anti-tumor immunity.

Authors:  Bartosz Wiernicki; Sophia Maschalidi; Jonathan Pinney; Sandy Adjemian; Tom Vanden Berghe; Kodi S Ravichandran; Peter Vandenabeele
Journal:  Nat Commun       Date:  2022-06-27       Impact factor: 17.694

8.  Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma.

Authors:  Behrouz Hassannia; Bartosz Wiernicki; Irina Ingold; Feng Qu; Simon Van Herck; Yulia Y Tyurina; Hülya Bayır; Behnaz A Abhari; Jose Pedro Friedmann Angeli; Sze Men Choi; Eline Meul; Karen Heyninck; Ken Declerck; Chandra Sekhar Chirumamilla; Maija Lahtela-Kakkonen; Guy Van Camp; Dmitri V Krysko; Paul G Ekert; Simone Fulda; Bruno G De Geest; Marcus Conrad; Valerian E Kagan; Wim Vanden Berghe; Peter Vandenabeele; Tom Vanden Berghe
Journal:  J Clin Invest       Date:  2018-06-25       Impact factor: 14.808

9.  In Vitro Studies on a Microfluidic Sensor with Embedded Obstacles Using New Antibacterial Synthetic Compounds (1-TDPPO) Mixed Prop-2-en-1-one with Difluoro Phenyl.

Authors:  Changhyun Roh; Jaewoong Lee; Mayank Kinger; Chankyu Kang
Journal:  Sensors (Basel)       Date:  2017-04-08       Impact factor: 3.576

10.  RIPK1-dependent cell death: a novel target of the Aurora kinase inhibitor Tozasertib (VX-680).

Authors:  Sofie Martens; Vera Goossens; Lars Devisscher; Sam Hofmans; Polien Claeys; Marnik Vuylsteke; Nozomi Takahashi; Koen Augustyns; Peter Vandenabeele
Journal:  Cell Death Dis       Date:  2018-02-12       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.